Tissue microarrays for high-throughput profiling in molecular oncology

Por Kallioniemi, O-P, Kononen, J, Sauter, G
Publicado em 2000

Androgen receptor gene and hormonal therapy failure of prostate cancer.

Por Koivisto, P., Kolmer, M., Visakorpi, T., Kallioniemi, O. P.
Publicado em 1998

Proliferating cell nuclear antigen immunohistochemistry using monoclonal antibody 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded nod...

Por Siitonen, S. M., Kallioniemi, O. P., Isola, J. J.
Publicado em 1993

Sensitive detection of chromosome copy number aberrations in prostate cancer by fluorescence in situ hybridization.

Por Visakorpi, T., Hyytinen, E., Kallioniemi, A., Isola, J., Kallioniemi, O. P.
Publicado em 1994

Genetic changes in intraductal breast cancer detected by comparative genomic hybridization.

Por Kuukasjärvi, T., Tanner, M., Pennanen, S., Karhu, R., Kallioniemi, O. P., Isola, J.
Publicado em 1997

Prognostic factors in recurrent breast cancer: relationships to site of recurrence, disease-free interval, female sex steroid receptors, ploidy and histological malignancy grading.

Por Blanco, G., Holli, K., Heikkinen, M., Kallioniemi, O. P., Taskinen, P.
Publicado em 1990

Serum CA 15-3 assay in the diagnosis and follow-up of breast cancer.

Por Kallioniemi, O. P., Oksa, H., Aaran, R. K., Hietanen, T., Lehtinen, M., Koivula, T.
Publicado em 1988

Analysis of genetic changes underlying local recurrence of prostate carcinoma during androgen deprivation therapy.

Por Koivisto, P., Hyytinen, E., Palmberg, C., Tammela, T., Visakorpi, T., Isola, J., Kallioniemi, O. P.
Publicado em 1995

Tumour DNA ploidy as an independent prognostic factor in breast cancer.

Por Kallioniemi, O. P., Blanco, G., Alavaikko, M., Hietanen, T., Mattila, J., Lauslahti, K., Koivula, T.
Publicado em 1987

c-erbB-2 in astrocytomas: infrequent overexpression by immunohistochemistry and absence of gene amplification by fluorescence in situ hybridization.

Por Haapasalo, H., Hyytinen, E., Sallinen, P., Helin, H., Kallioniemi, O. P., Isola, J.
Publicado em 1996

Nuclear DNA content of non-endemic Burkitt's lymphoma.

Por Lehtinen, T, Lehtinen, M, Aine, R, Kallioniemi, O P, Leino, T, Hakala, T, Leinikki, P, Alavaikko, M
Publicado em 1987

Flow cytometric analysis of DNA ploidy and S-phase fraction from prostatic carcinomas: implications for prognosis and response to endocrine therapy.

Por Visakorpi, T., Kallioniemi, O. P., Paronen, I. Y., Isola, J. J., Heikkinen, A. I., Koivula, T. A.
Publicado em 1991

Defective autologous mixed leukocyte reaction in newly diagnosed type 1 diabetes mellitus.

Por Räsänen, L, Hyöty, H, Lehto, M, Kallioniemi, O P, Antonen, J, Huupponen, T, Karjalainen, J, Leinikki, P
Publicado em 1988

Molecular cytogenetic analysis of 11 new breast cancer cell lines

Por Forozan, F, Veldman, R, Ammerman, C A, Parsa, N Z, Kallioniemi, A, Kallioniemi, O-P, Ethier, S P
Publicado em 1999

Genetic changes associated with the acquisition of androgen-independent growth, tumorigenicity and metastatic potential in a prostate cancer model.

Por Hyytinen, E. R., Thalmann, G. N., Zhau, H. E., Karhu, R., Kallioniemi, O. P., Chung, L. W., Visakorpi, T.
Publicado em 1997

A missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A2) is not associated with prostate cancer in Finland

Por Mononen, N, Ikonen, T, Syrjäkoski, K, Matikainen, M, Schleutker, J, Tammela, T L J, Koivisto, P A, Kallioniemi, O P
Publicado em 2001

Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer.

Por Isola, J. J., Kallioniemi, O. P., Chu, L. W., Fuqua, S. A., Hilsenbeck, S. G., Osborne, C. K., Waldman, F. M.
Publicado em 1995

Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization.

Por Kallioniemi, A, Kallioniemi, O P, Piper, J, Tanner, M, Stokke, T, Chen, L, Smith, H S, Pinkel, D, Gray, J W, Waldman, F M
Publicado em 1994

ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization.

Por Kallioniemi, O P, Kallioniemi, A, Kurisu, W, Thor, A, Chen, L C, Smith, H S, Waldman, F M, Pinkel, D, Gray, J W
Publicado em 1992

Germline TP53 alterations in Finnish breast cancer families are rare and occur at conserved mutation-prone sites

Por Rapakko, K, Allinen, M, Syrjäkoski, K, Vahteristo, P, Huusko, P, Vähäkangas, K, Eerola, H, Kainu, T, Kallioniemi, O-P, Nevanlinna, H, Winqvist, R
Publicado em 2001